Tesamorelin
A GHRH analog studied in visceral adipose and GH-release research models.
Half-life
~26 min (pulsatile action)
Typical vial
2 mg / 5 mg
Mechanism
Binds GHRH receptors in the pituitary, studied for stimulating endogenous GH release.
Research Applications
- GH stimulation
- Visceral adipose research
- Lipid profile studies
Handling & Storage
Store lyophilized at -20°C. Reconstitute and refrigerate.
Compliance notice: All materials are sold strictly for in vitro laboratory research. Not a drug, supplement, food, or cosmetic. Not for human or veterinary use, diagnosis, treatment, or consumption. No medical claims are made or implied. Buyers must be qualified researchers ≥21 years of age and agree to handle materials in compliance with all applicable local, state, and federal laws.